How The Pulmonx (LUNG) Investment Narrative Is Resetting Around A Lower Target And Execution Risk [Yahoo! Finance]
Pulmonx Corporation (LUNG)
US:NASDAQ Investor Relations:
investor.prolunginc.com/investor-relations
Company Research
Source: Yahoo! Finance
Pulmonx now sits under a reset US$5 price target, with the fair value estimate holding at US$5.17 per share, signalling that the core valuation framework has not been reworked. Bullish analysts see this as a more grounded bar for execution, while bearish voices read it as a mark of lowered near term expectations despite Q4 results being described as largely in line. Read on to see how to interpret these shifting narratives and keep track of what really matters as the story develops. Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value Pulmonx. What Wall Street Has Been Saying ?? Bullish Takeaways Canaccord, through analyst William Plovanic, kept a Buy rating on Pulmonx even as the firm reset its price target to US$5. This indicates ongoing confidence in the equity story despite a lower bar. Canaccord highlighted that Q4 results were largely in line with expectations, suggesting that, for now, the current earnin
Show less
Read more
Impact Snapshot
Event Time:
LUNG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LUNG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LUNG alerts
High impacting Pulmonx Corporation news events
Weekly update
A roundup of the hottest topics
LUNG
News
- Pulmonx to Report First Quarter 2026 Financial Results on April 29, 2026GlobeNewswire
- How The Pulmonx (LUNG) Investment Story Is Shifting After Q4 And New Guidance [Yahoo! Finance]Yahoo! Finance
- How The Pulmonx (LUNG) Narrative Is Resetting Around Execution Risks And Fair Value Assumptions [Yahoo! Finance]Yahoo! Finance
- Pulmonx (LUNG) had its price target lowered by Canaccord Genuity Group Inc. from $6.00 to $5.00. They now have a "buy" rating on the stock.MarketBeat
- Pulmonx (LUNG) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $14.00 price target on the stock.MarketBeat
LUNG
Earnings
- 3/4/26 - Beat
LUNG
Analyst Actions
- 3/5/26 - Canaccord Genuity
LUNG
Sec Filings
- 4/22/26 - Form ARS
- 4/22/26 - Form DEF
- 4/22/26 - Form DEFA14A
- LUNG's page on the SEC website